LU
Lunai Bioworks Inc.
RENB | US
Overview
Corporate Details
- ISIN(s):
- US29350E1047
- LEI:
- Country:
- United States of America
- Address:
- CENTURY CITY MEDICAL PLAZA, 90067 SUITE 906 LOS ANGELES
- Website:
- https://www.lunaibio.com
- Sector:
- Professional, scientific and technical activities
- Industry:
- Research and experimental development on natural sciences and engineering
Description
No description available.
Unlock This Filing & Millions More
You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.
Filings
You have of free filing views remaining.
Upgrade for unlimited access.
Bulk Actions:
| Date | Filing | Language | Size | Actions | |
|---|---|---|---|---|---|
| No filings match the current criteria. | |||||
Automate Your Workflow. Get a real-time feed of all Lunai Bioworks Inc. filings delivered via API.
Market Data
Market Data Not Available
Last Price
Change / %
Market Cap
N/A
Volume
Day High
Day Low
52W High
52W Low
Financials & KPIs
No data available
Unlock Full Financials for Lunai Bioworks Inc.
This data is available as part of our premium data solutions. Contact our team for access.
Need More History? Access decades of standardized financials for Lunai Bioworks Inc. via our API.
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| No insider transactions recorded for this company. | |||||
Peer Companies
Company
Country
Ticker
View
Developing viral immunotherapies like vaccines and oncolytic viruses to treat solid tumors.
France
TNG
France
TNG
Offers drug discovery CRO services (gene editing, trials) and business investment/consulting.
Japan
2342
Japan
2342
Oncology tech firm enhancing drug delivery and immunotherapy for solid liver & pancreas tumors.
United States of America
TLSI
United States of America
TLSI
Developing TCR-engineered T-cell therapies for solid and hematologic cancers.
United States of America
TCRX
United States of America
TCRX
Developing pharmaceuticals and medical devices for ophthalmic and brain diseases.
Japan
4890
Japan
4890
Phase 3 immuno-oncology firm developing therapeutics to overcome cancer therapy resistance.
United States of America
HURA
United States of America
HURA
Biotech developing precision FGFR medicines for cancer and genetic disorders.
United States of America
TYRA
United States of America
TYRA
A nonprofit consortium managing atmospheric research and providing resources to the scientific community.
France
ALUCR
France
ALUCR
Provides a portable platform for rapid point-of-need genetic analysis and diagnostics.
Italy
UBM
Italy
UBM
Develops and licenses OLED technologies and materials for the display and lighting industries.
United States of America
OLED
United States of America
OLED